Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (29)
- Computing and Computational Sciences Directorate (39)
- Energy Science and Technology Directorate (229)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate
(138)
- User Facilities (28)
Researcher
- Adam M Guss
- Josh Michener
- Liangyu Qian
- Yong Chae Lim
- Zhili Feng
- Andrzej Nycz
- Austin L Carroll
- Biruk A Feyissa
- Carrie Eckert
- Daniel Jacobson
- Isaiah Dishner
- Jeff Foster
- Jian Chen
- John F Cahill
- Kuntal De
- Rangasayee Kannan
- Serena Chen
- Udaya C Kalluri
- Vilmos Kertesz
- Wei Zhang
- Xiaohan Yang
- Adam Stevens
- Alex Walters
- Brian Post
- Brian Sanders
- Bryan Lim
- Chris Masuo
- Clay Leach
- Dali Wang
- Debjani Pal
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Jay D Huenemann
- Jerry Parks
- Jiheon Jun
- Joanna Tannous
- Kyle Davis
- Nandhini Ashok
- Paul Abraham
- Peeyush Nandwana
- Priyanshi Agrawal
- Roger G Miller
- Ryan Dehoff
- Sarah Graham
- Sudarsanam Babu
- Tomas Grejtak
- Vincent Paquit
- William Alexander
- William Peter
- Yang Liu
- Yasemin Kaygusuz
- Yiyu Wang
- Yukinori Yamamoto

ORNL has developed bacterial strains that can utilize a common plastic co-monomer as a feedstock. This will help enable modern, petroleum-derived plastics to be converted into value-added chemicals.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Due to a genes unique nucleotide sequences acquired through horizontal gene transfer, the gene has a transcriptional repressor activity and innate enzymatic role.

We have developed bacterial strains that can convert sustainable feedstocks and waste feedstocks into chemical precursors for next generation plastics.

ORNL has identified a panel of novel nylon hydrolases with varied substrate and product selectivity.

Genetic modification of microbes that are thermophiles—ones that grow at elevated temperatures—is extremely challenging. Tools developed for E. coli, a typical host for protein production, typically do not function at elevated temperatures.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.

The invention provides a gene and methods for maintaining meiotic chromosomal architecture